The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
27-Hydroxycholesterol Promotes Cell-Autonomous, ER-Positive Breast Cancer Growth
Open accessAbstract
To date, estrogen is the only known endogenous estrogen receptor (ER) ligand that promotes ER+ breast tumor growth. We report that the cholesterol metabolite 27-hydroxycholesterol (27HC) stimulates MCF-7 cell xenograft growth in mice. More importantly, in ER+ breast cancer patients, 27HC content in normal breast tissue is increased compared to that in cancer-free controls, and tumor 27HC content is further elevated. Increased tumor 27HC is correlated with diminished expression of CYP7B1, the 27HC metabolizing enzyme, and reduced expression of CYP7B1 in tumors is associated with poorer patient survival. Moreover, 27HC is produced by MCF-7 cells, and it stimulates cell-autonomous, ER-dependent, and GDNF-RET-dependent cell proliferation. Thus, 27HC is a locally modulated, nonaromatized ER ligand that promotes ER+ breast tumor growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
The Enzymes, Regulation, and Genetics of Bile Acid Synthesis
Russell, D. W. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161712 · Cited by 2,069
ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics
McPherson, K. (2000) · BMJ · doi:10.1136/bmj.321.7261.624 · Cited by 1,570
Structural requirements of ligands for the oxysterol liver X receptors LXRα and LXRβ
Janowski, B. A., Grogan, M. J., Jones, S. A., Wisely, G. B., Kliewer, S. A., Corey, E. J., & Mangelsdorf, D. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.266 · Cited by 942
Overweight, obesity, and cancer risk
Bianchini, F., Kaaks, R., & Vainio, H. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00849-5 · Cited by 929
Oxysterols and atherosclerosis
Brown, A. J., & Jessup, W. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00196-8 · Cited by 919
Etiology of Hormone Receptor–Defined Breast Cancer: A Systematic Review of the Literature
Althuis, M. D., Fergenbaum, J. H., Garcia-Closas, M., Brinton, L. A., Madigan, M. P., & Sherman, M. E. (2004) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.1558.13.10 · Cited by 628
Dzeletovic, S., Breuer, O., Lund, E., & Diczfalusy, U. (1995) · Analytical Biochemistry · doi:10.1006/abio.1995.1110 · Cited by 570
The estrogen receptor: a model for molecular medicine.
Jensen, E. V., & Jordan, V. C. (2003) · PubMed · Cited by 470
27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen
Umetani, M., Domoto, H., Gormley, A. K., Yuhanna, I. S., Cummins, C. L., Javitt, N. B., Korach, K. S., Shaul, P. W., & Mangelsdorf, D. J. (2007) · Nature Medicine · doi:10.1038/nm1641 · Cited by 396
Self-citationRole of Cholesterol in the Development and Progression of Breast Cancer
Llaverias, G., Danilo, C., Mercier, I., Daumer, K., Capozza, F., Williams, T. M., Sotgia, F., Lisanti, M. P., & Frank, P. G. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2010.11.005 · Cited by 327
27-Hydroxycholesterol Is an Endogenous Selective Estrogen Receptor Modulator
DuSell, C. D., Umetani, M., Shaul, P. W., Mangelsdorf, D. J., & McDonnell, D. P. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0383 · Cited by 301
Self-citationQiu, R.-G., Abo, A., & Martin, G. S. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00535-2 · Cited by 276
Serum High-Density Lipoprotein Cholesterol, Metabolic Profile, and Breast Cancer Risk
Furberg, A.-S., Veierod, M. B., Wilsgaard, T., Bernstein, L., & Thune, I. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh216 · Cited by 264
Chambliss, K. L., Wu, Q., Oltmann, S., Konaniah, E. S., Umetani, M., Korach, K. S., Thomas, G. D., Mineo, C., Yuhanna, I. S., Kim, S. H., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci38291 · Cited by 250
Self-citationDisruption of the Oxysterol 7α-Hydroxylase Gene in Mice
Li-Hawkins, J., Lund, E. G., Turley, S. D., & Russell, D. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001811200 · Cited by 246
McDonald, J. G., Smith, D. D., Stiles, A. R., & Russell, D. W. (2012) · Journal of Lipid Research · doi:10.1194/jlr.d022285 · Cited by 237
Self-citationAntagonists Selective for Estrogen Receptor α
Sun, J., Huang, Y. R., Harrington, W. R., Sheng, S., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (2002) · Endocrinology · doi:10.1210/endo.143.3.8704 · Cited by 236
Zhang, Y., Breevoort, S. R., Angdisen, J., Fu, M., Schmidt, D. R., Holmstrom, S. R., Kliewer, S. A., Mangelsdorf, D. J., & Schulman, I. G. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59817 · Cited by 213
Animal models of hypertension: An overview
Lerman, L. O., Chade, A. R., Sica, V., & Napoli, C. (2005) · Journal of Laboratory and Clinical Medicine · doi:10.1016/j.lab.2005.05.005 · Cited by 197
The oxysterol receptor LXR inhibits proliferation of human breast cancer cells
Vedin, L.-L., Lewandowski, S. A., Parini, P., Gustafsson, J.-Å., & Steffensen, K. R. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp029 · Cited by 194
Estrogen Receptor α Mediates 17α-Ethynylestradiol Causing Hepatotoxicity
Yamamoto, Y., Moore, R., Hess, H. A., Guo, G. L., Gonzalez, F. J., Korach, K. S., Maronpot, R. R., & Negishi, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602723200 · Cited by 178
Why Syndrome X? From Harold Himsworth to the insulin resistance syndrome.
Reaven, G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.001 · Cited by 158
Lappano, R., Recchia, A. G., Francesco, E. M. D., Angelone, T., Cerra, M. C., Picard, D., & Maggiolini, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016631 · Cited by 122
Burkard, I., von Eckardstein, A., Waeber, G., Vollenweider, P., & Rentsch, K. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.09.026 · Cited by 103
Effect of Obesity on Breast Cancer Development
Cleary, M. P., Grossmann, M. E., & Ray, A. (2010) · Veterinary Pathology · doi:10.1177/0300985809357753 · Cited by 100
RET in breast cancer: functional and therapeutic implications
Morandi, A., Plaza-Menacho, I., & Isacke, C. M. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.12.007 · Cited by 96
Labhart, P., Karmakar, S., Salicru, E. M., Egan, B. S., Alexiadis, V., O’Malley, B. W., & Smith, C. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409578102 · Cited by 95
Obesity Accelerates Mouse Mammary Tumor Growth in the Absence of Ovarian Hormones
Núñez, N. P., Perkins, S. N., Smith, N. C. P., Berrigan, D. A., Berendes, D. M., Varticovski, L., Barrett, J. C., & Hursting, S. D. (2008) · Nutrition and Cancer · doi:10.1080/01635580801966195 · Cited by 91
Vollmer, G. (2003) · Endocrine Related Cancer · doi:10.1677/erc.0.0100023 · Cited by 89
Postmenopausal obesity promotes tumor angiogenesis and breast cancer progression in mice
Gu, J., Young, E., Patterson, S. G., Makey, K. L., Wells, J. B., Huang, M. H., Tucker, K. B., & Miele, L. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.10.15473 · Cited by 85
Roz, A. E., Bard, J., Huvelin, J., & Nazih, H. (2012) · PubMed · Cited by 82
Michalaki, V., Koutroulis, G., Koutroulis, G., Syrigos, K., Piperi, C., & Kalofoutis, A. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-2993-4 · Cited by 75
What do we know about the mechanisms of aromatase inhibitor resistance?
Chen, S., Masri, S., Wang, X., Phung, S., Yuan, Y.-C., & Wu, X. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.09.012 · Cited by 64
Dunbier, A. K., Anderson, H., Ghazoui, Z. F., López‐Knowles, E., Pancholi, S., Ribas, R., Drury, S., Sidhu, K., Leary, A. F., Martin, L., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001382 · Cited by 58
Optimizing the antihormonal treatment and prevention of breast cancer
Patel, R. R., Sharma, C. G. N., & Jordan, V. C. (2007) · Breast Cancer · doi:10.2325/jbcs.966 · Cited by 35
Hansson, M. E. A., Ellis, E. C. S., Hunt, M. C., Schmitz, G., & Babiker, A. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00398-1 · Cited by 31
Tang, W., Pettersson, H. I., & Norlin, M. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.08.004 · Cited by 16
Cited by
The cancer metabolic reprogramming and immune response
Xia, L., Oyang, L., Lin, J., Tan, S., Han, Y., Wu, N., Yi, P., Tang, L., Pan, Q., Rao, S., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01316-8 · Cited by 1,312
Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities
Huang, B., Song, B.-L., & Xu, C. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0174-0 · Cited by 921
Metabolism of immune cells in cancer
Leone, R. D., & Powell, J. D. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0273-y · Cited by 877
Natural killer cells in cancer biology and therapy
Wu, S.-Y., Fu, T., Jiang, Y.-Z., & Shao, Z.-M. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01238-x · Cited by 863
The Role of Cholesterol in Cancer
Kuzu, O. F., Noory, M. A., & Robertson, G. P. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2613 · Cited by 708
Metadata
- Authors
- Wu, Q., Ishikawa, T., Sirianni, R., Tang, H., McDonald, J. G., Yuhanna, I. S., Thompson, B., Girard, L., Mineo, C., Brekken, R. A., Umetani, M., Euhus, D. M., Xie, Y., & Shaul, P. W.
- Venue
- Cell Reports
- Publisher
- Elsevier BV
- Published
- 2013-11
- Volume
- 5
- Issue
- 3
- Pages
- 637-645
- ISSN
- 2211-1247 (ISSN-L)
- OpenAlex
- W2036192035
- Cited by
- 358
- References
- 39
- FWCI
- 16.99
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.